Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202311864433214Not yet recruiting
Open-label trial of human insulin and metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Innocent Abah Ochigbo. Primary endpoint: Maternal glycaemic control. Planned start Oct 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202311864433214.